ArticleJournal of imaging2025
Efficient Retinal Vessel Segmentation with 78K Parameters.
Article in Journal of imaging, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- nnLoGoNet: a hybrid local-global network for retinal vessel segmentation with Skeleton Recall Loss.Scientific reports · 2026Article
- Few-shot annotation correction for lightweight retinal vessel image segmentation.Frontiers in medicine · 2026Article
- Gated Attention-Augmented Double U-Net for White Blood Cell Segmentation.Journal of imaging · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Retinal vessel segmentation is critical for early diagnosis of diabetic retinopathy, yet existing deep models often compromise accuracy for complexity. We propose DSAE-Net, a lightweight dual-stage network that addresses this challenge by (1) introducing a Parameterized Cascaded W-shaped Architecture enabling progressive feature refinement with only 1% of the parameters of a standard U-Net; (2) designing a novel Skeleton Distance Loss (SDL) that overcomes boundary loss limitations by leveraging vessel skeletons to handle severe class imbalance; (3) developing a Cross-modal Fusion Attention (CMFA) module combining group convolutions and dynamic weighting to effectively expand receptive fields; and (4) proposing Coordinate Attention Gates (CAGs) to optimize skip connections via directional feature reweighting. Evaluated extensively on DRIVE, CHASE_DB1, HRF, and STARE datasets, DSAE-Net significantly reduces computational complexity while outperforming state-of-the-art lightweight models in segmentation accuracy. Its efficiency and robustness make DSAE-Net particularly suitable for real-time diagnostics in resource-constrained clinical settings.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.